• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home Wellness

Automated pupillometry may be helpful in opioid agonist therapy dosing for opioid use disorder

byNancy LuandAvneesh Bhangu
November 29, 2021
in Wellness
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this study, automated pupillometry demonstrated a significant change in mean pupil size detected within 15 minutes of opiate agonist therapy dosing amongst patients treated for opioid use disorder.

2. This study also found that there may be a threshold change in pupil size that may indicate good withdrawal symptom control.

Evidence Rating Level: 3 (Average) 

Many patients with opioid use disorder (OUD) find it difficult to manage due to withdrawal symptoms; thus, the dosage of opioid agonist therapy (OAT) needed to control withdrawal symptoms is an important question. Current protocols use the validated Clinical Opiate Withdrawal Scale (COWS), which includes a measurement of pupil size that has low precision and high interobserver variability. More precise measures of pupil size and reactivity could help eliminate this high interobserver variability. As such, this pilot study examined whether automated pupillometry may be more accurate in helping quantify opioid withdrawal amongst patients receiving OAT

This pilot study included patients aged 18-50 with OUD who were admitted to Boston Medical Center, Boston, Massachusetts, United States of America and received recommendations on OAT from the inpatient Addiction Consult Service between March and December 2018. Urine toxicology screening was performed to confirm opioid use. Participants were included if they consented to the pupillometry measurements, which were performed with the NeurOptics NPi-200 (n=27). Measured variables included pupil sizes (in light and dark illumination), latency of the pupillary light response, and percent constriction at varying timepoints pre-and post-OAT.

The analyses demonstrated a small but significant change in pupil size within 15 minutes of OAT administration when measured by the automated pupillometer, which persisted at later timepoints. Additionally, patients with well-controlled withdrawal symptoms had a significantly greater change in pupil size 60 minutes after OAT dosing compared to patients with high (therefore worse) COWS scores. This indicated there may be a threshold change in pupil size that corresponds with good symptom control. However, this pilot study was limited due to its small sample size which did not allow for sub-group analyses. Despite these limitations, this study demonstrated the potential viability of automated pupillometry in OAT dosing as a quantitative measure of withdrawal symptoms.

Click to read the study in Journal of Addiction Medicine

RELATED REPORTS

Buprenorphine in pregnancy is associated with lower neonatal risk than methadone

Co-use of methamphetamine and opioids associated with higher rates of nonfatal overdoses compared to independent use

Post-operative opioids at discharge increase adverse events without improving pain management

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: COWSopioidopioid agonistopioid use disorderOUDpupillometry
Previous Post

Postoperative chemotherapy in chemosensitive patients undergoing surgical treatment of gastric cancer may prolong survival

Next Post

#VisualAbstract High cost of healthcare was the highest patient-reported barrier to accessing outpatient dermatologic care

RelatedReports

Patients with low back pain or pain at multiple sites at highest risk for chronic opioid use
Chronic Disease

Buprenorphine in pregnancy is associated with lower neonatal risk than methadone

December 8, 2022
Patients with low back pain or pain at multiple sites at highest risk for chronic opioid use
Chronic Disease

Co-use of methamphetamine and opioids associated with higher rates of nonfatal overdoses compared to independent use

August 20, 2022
Parental nonmedical prescription opioid use linked to adolescent use
Chronic Disease

Post-operative opioids at discharge increase adverse events without improving pain management

June 28, 2022
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Wellness

Spectrophotometric assays for methadone may be effective for diversion control

April 26, 2022
Next Post
#VisualAbstract High cost of healthcare was the highest patient-reported barrier to accessing outpatient dermatologic care

#VisualAbstract High cost of healthcare was the highest patient-reported barrier to accessing outpatient dermatologic care

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]

The Child-Pugh score: Prognosis in chronic liver disease and cirrhosis [Classics Series]

2 Minute Rewind November 29, 2021

2 Minute Rewind November 29, 2021

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deep intronic FGF14 repeat expansion associated with late-onset cerebella ataxia
  • Plant-based diets may be associated with lower risk of aggressive prostate cancer
  • #VisualAbstract: Adagrasib provides antitumour activity against KRAS G12C mutant metastatic colorectal cancer both as monotherapy and in combination with cetuximab
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options